84-1156-33 PARK2, NT (E3 Ubiquitin-protein Ligase Parkin, PRKN, Parkinson Juvenile Disease Protein 2, Parkinson Disease Protein 2) 200ul P3112-02E
特徴
- Parkinson is the second most common neurodegenerative disease after Alzheimers.
- About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease.
- The mutation is the most common cause of Parkinson disease identified to date.
- The function of Park2 is not well-known; however, it may play a role in the ubiquitin-mediated proteolytic pathway.
- Mutations in this gene are known to cause autosomal recessive juvenile parkinsonism.
- Alternative splicing of this gene produces three known products of undetermined function.
- Applications:Suitable for use in ELISA and Western Blot.
- Other applications not tested.
- Recommended Dilution:ELISA: 1:1,000Western Blot: 1:100-1:500Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for at least 12 months.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:200ul
- Host:rabbit
- Source Antibody:human
- Grade:Purified
- Purity:Purified by ammonium sulfate precipitation.
- Form:Supplied as a liquid in PBS, 0.09% sodium azide.
- Specificity:Recognizes human Park2.
- Isotype:IgG
- Calc Applications Abbrev:E WB
- Calc Crossreactivity:Hu
- Immunogen:Synthetic peptide in the C-terminal region of human Park2 (KLH).
- Shelf Life:1year
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]